The assessment of efficacy and safety of Irreversible Electroporation(IRE) to treat unresectable locally advanced pancreatic cancer
Not Applicable
- Conditions
- nresectable locally advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000016423
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1. distant metastasis, 2. CT or MRI contrast agent allergy, 3. Another organs malignancy, 4. Pregnant women or women of childbearing potential not using an acceptable method of contraception, 5. Uncontrolled infection 6. Heart failure, coronary artery disease or arrhythmia in progress, active implantable devices (eg pacemaker) 7 Patient's disability to stop anticoagulant and anti platelet therapy 8. Attending physician determines that inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of IRE for treatmetn of unresectable locally advanced pancreatic cancer according to local control rate using CT or MRI performed 6 months after treatment
- Secondary Outcome Measures
Name Time Method Incidence and kind of adverse events of up to 1 month after treatment